Drugs
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 06/24/13 -- Flamel Technologies S.A. (NASDAQ: FLML) today announced voting results from the Company's annual ordinary and extraordinary meeting held on June 20, ...
PARIS, FRANCE: EDITION I Demonstrated Similar Blood Sugar Control With Fewer Night-Time Low Blood Sugar Events Compared to Lantus(R) Topline Results of EDITION II Consistent With EDITION I Findings ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/21/13 -- Theravance, Inc. (NASDAQ: THRX) today announced that the U.S. Food and Drug Administration (FDA) has approved VIBATIV® (telavancin) for the tr ...
SOUTH SAN FRANCISCO, CA: Theravance remains focused on strategy to separate late-stage partnered respiratory assets from biopharmaceutical operations ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/13/13 -- Biologix Hair Inc. (OTCBB: BLGX)(OTCQB: BLGX) has appointed Leila Bloch, MD to the Company's Medical Advisory Board, where she will serve with Dr ...
TORONTO, ONTARIO: Successful Technological and Economic achievements pave way for commercial production ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/10/13 -- Biologix Hair Inc. (OTCBB: BLGX)(OTCQB: BLGX) announces that the Company has given notice of its 2013 Annual Meeting of Stockholders.The 2013 Annual M ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 06/06/13 -- Flamel Technologies (NASDAQ: FLML) today announced a multi-year development partnership agreement with an undisclosed, large international pharmaceutical ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/06/13 -- Biologix Hair Inc. (OTCBB: BLGX)(OTCQB: BLGX) has released a detailed report on the progress of Beijing Institute of Technology toward refining and st ...
TORONTO, ONTARIO: Acceptance into larger retailers and Club Stores stimulated by increased publicity ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/04/13 -- Theravance, Inc. (NASDAQ: THRX), a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collabor ...
STONY BROOK, NY: STONY BROOK, NY -- (Marketwired) -- 06/04/13 -- . (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, anti-theft and product authentication solutions, today annou ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/03/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) is pleased to report the Company's clinician licensing results for the period commencing March 1 t ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/31/13 -- Biologix Hair Inc. (OTCBB: BLGX)(OTCQB: BLGX) announces that effective June 1, 2013 Ottawa-based Launch IR has been retained to manage investor relati ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/30/13 -- ., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's innate immun ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/29/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) is pleased to announce the signing of a Letter of Intent (LOI) to cr ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/29/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) today announced the link for the live webcast at the 2nd Annual Marc ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwired) -- 05/28/13 -- (NASDAQ: PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. Patent application 13/105 ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 05/28/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/23/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at t ...
